5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression
about
Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1Cloning and partial characterization of the mouse glutamine:fructose-6-phosphate amidotransferase (GFAT) gene promoterCyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcriptionHuman ZNF312b oncogene is regulated by Sp1 binding to its promoter region through DNA demethylation and histone acetylation in gastric cancer.Negative methylation status of vimentin predicts improved prognosis in pancreatic carcinoma.Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa.Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemiap53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility.Functional analysis of the V gamma 3 promoter of the murine gamma delta T-cell receptorSuppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression.Transcription regulation and protein subcellular localization of the truncated basic hair keratin hHb1-DeltaN in human breast cancer cells.Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.An Sp1 binding site and the minimal promoter contribute to overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line.Cadmium down-regulates human OGG1 through suppression of Sp1 activity.The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells.Structural and functional analysis of the promoter of the murine V gamma 1.1 T cell receptor gene.Epidermal growth factor stimulation of the human gastrin promoter requires Sp1.Constitutive expression of human intercellular adhesion molecule-1 (ICAM-1) is regulated by differentially active enhancing and silencing elements.Interaction of the transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62.Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene.Post-translational modification by O-GlcNAc: another way to change protein function.
P2860
Q22254112-71AE0633-2245-4D9A-95BD-D233BCC145A5Q28587198-28B3BD3D-5BC1-4A33-B74E-9BA256F7F69DQ33884776-FA876033-F822-44C3-94E0-AD823CEB4F8EQ34042749-776A22C7-418C-4503-A781-B6E1A178C4F1Q34155688-2133C7D7-2F73-4760-8A27-8E011F35CF63Q34255579-D12349E2-0201-4741-962F-015440C69F80Q34498017-3DF0764A-8740-4E68-8039-6BA5D3E1B257Q35191080-53CA227D-1B64-4BF6-8D24-9C730BF2DBA6Q35377397-0E097A27-56BF-4546-864F-F5735B5D97D4Q36554148-72637C9C-419C-49D6-B251-3CD0DA68AB2DQ36568052-FFCA132F-8D24-4185-8C33-7B8F29BABD7CQ36644772-FD4752FF-D53E-4E85-ADB8-94A4F4A6F8D8Q38300283-8C66BC56-D10F-45F2-9C69-730110BAA1E6Q38301963-5D54F5AD-9142-4550-AB4E-EC9C4BC5AA50Q38307585-5EC5C321-CF1C-4B58-9FE9-9C593B1B66E0Q38336378-43F5C9D6-15C8-4186-B444-FF70469BF6B0Q38342368-0155D0CA-77AF-4696-8CE0-15A2E4492689Q40016186-250EC487-E5A8-4DA7-87A0-6896E2257378Q40448068-C446E086-5422-4E0B-825D-2CA1A4E2C0BAQ41239623-2AD8FA4A-996F-4975-B725-7B92EFD6D6FBQ41279368-AA870A98-8E48-49AA-AAB9-C745AD1234E4Q41359086-0E58DEC4-E808-4DE1-AD35-5AF1BD4BAC87Q41365660-DB5BB59D-9168-4BC3-A391-5AC5D95D51C0Q44560864-148F6BB4-8CEA-4283-8425-07F6FE3C00B8Q45345483-A07D94B0-687F-407F-996B-73A21D92799FQ53628581-3E7C874D-257C-436E-B179-BB26B7CBCC3F
P2860
5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@ast
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@en
type
label
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@ast
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@en
prefLabel
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@ast
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@en
P2093
P2860
P356
P1476
5-Azacytidine treatment of HA- ...... growth factor alpha expression
@en
P2093
A A Meluch
A J Paterson
J E Kudlow
P2860
P304
P356
10.1128/MCB.12.9.3998
P407
P577
1992-09-01T00:00:00Z